Home > Financial Ratios > EMCURE PHARMACEUTICALS

EMCURE PHARMACEUTICALS
Working Capital/Sales

    Back to All Ratios
EMCURE PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
AD     Remove this Ad

EMCURE PHARMACEUTICALS Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Working Capital/Sales(x) 4.256.507.4713.0220.21

What is the latest Working Capital/Sales ratio of EMCURE PHARMACEUTICALS ?

The latest Working Capital/Sales ratio of EMCURE PHARMACEUTICALS is 4.25 based on Mar2025 Consolidated results.
Year Working Capital/Sales
Mar20254.25
Mar20246.50
Mar20237.47
Mar202213.02
Mar202120.21

How is Working Capital/Sales of EMCURE PHARMACEUTICALS Trending?

Years Working Capital/Sales % Change
Mar2025 4.25
-34.62
Mar2024 6.5
-12.99
Mar2023 7.47
-42.63
Mar2022 13.02
-35.58
Mar2021 20.21 -

Other Financial Ratios of EMCURE PHARMACEUTICALS


Compare Working Capital/Sales ratio of peers of EMCURE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS ₹29,107.4 Cr 4.8% 2.9% 23.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹408,847.0 Cr 6.8% -1.5% -2.4% Stock Analytics
DIVIS LABORATORIES ₹160,745.0 Cr 0% -4.8% 8.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹136,346.0 Cr 1.7% 4.1% 20.5% Stock Analytics
CIPLA ₹107,075.0 Cr 0.1% -12.8% -9.3% Stock Analytics
DR REDDYS LABORATORIES ₹103,507.0 Cr 1.8% -0.7% 3.4% Stock Analytics


EMCURE PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS

4.8%

2.9%

23.5%

SENSEX

1.5%

-2.3%

9.5%


You may also like the below Video Courses